Initiatives & Tools
The Cancer Immunotherapy Consortium has served the cancer immunotherapy community since 2002 and has made significant contributions to progress in the field. Through seminars, workshops, working groups, and online consensus-building projects supported by immunological and clinical data from cancer immunotherapy trials, the Consortium works to address several of the key issues facing the cancer immunotherapy field.
The Minimal Information About T cell Assays (MIATA) Project provides recommendations on the minimum information required to allow an objective and thorough interpretation of published results from immunological T cell assays.
Community initiatives help foster interaction and collaboration among Consortium members and promotes alliances with partner academic and industrial organizations.
Member-only workshops and working groups address regulatory issues and aim to define and overcome targeted challenges in cancer immunotherapy development.
Meetings & Workshops
Meetings, conferences, and workshops allow for networking and the exchange of information among members and the greater cancer immunotherapy field.